TOI, Y.; KIMURA, Y.; DOMEKI, Y.; KAWANA, S.; AIBA, T.; ONO, H.; ASOU, M.; TSURUMI, K.; SUZUKI, K.; SHIMIZU, H.; SUGISAKA, J.; SAITO, R.; TERAYAMA, K.; KAWASHIMA, Y.; NAKAMURA, A.; YAMANDA, S.; HONDA, Y.; SUGAWARA, S. Association of low body surface area with dose reduction and/or discontinuation of nintedanib in patients with idiopathic pulmonary fibrosis: a pilot study: BSA and nintedanib reduction/discontinuation. Sarcoidosis, Vasculitis and Diffuse Lung Disease, [S. l.], v. 36, n. 1, p. 74–78, 2019. DOI: 10.36141/svdld.v36i1.7383. Disponível em: https://mattioli1885journals.com/index.php/sarcoidosis/article/view/7383. Acesso em: 28 sep. 2021.